StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report released on Wednesday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Down 80.8 %
NYSE AMPE opened at $0.00 on Wednesday. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $2.91. The stock has a market cap of $567.50, a P/E ratio of 0.00 and a beta of 3.66. The company’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.03.
About Ampio Pharmaceuticals
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- Dividend Capture Strategy: What You Need to Know
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- What Are Dividend Champions? How to Invest in the Champions
- How AI Implementation Could Help MongoDB Roar Back in 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
